Towards Healthcare

Bio-Techne and Saguaro enter a distribution agreement

Saguaro Biosciences partners with Bio-Techne to distribute non-toxic live cell dyes, improving cell assays and drug development research globally.

Category: Business Published Date: 20 October 2025
Share : Healthcare Services Healthcare Services Healthcare Services Healthcare Services Healthcare Services

Bio-Techne partners with Saguaro for distribution

Image Credit: Stock Titan

Announcement 

The Saguaro Biosciences, a leader in non-toxic live cell reagents for improved drug insights, has entered a distributive partnership agreement with Bio-Techne Corporation, a leading provider of science tools, diagnostic and reagents products. The collaboration will elevate Bio-Techne’s expansive commercialize channels and overseas sales to deliver improved access for Saguaro’s portfolio of wash-free, non-toxic dyes to the researchers.

This smart partnership is engineered to successfully fill the accelerating demand for upgraded reagents that allow physiologically matchable and superior throughput cell-related assays. The collaboration will primarily focus on the saguaro’s dyes’ distribution, consisting of nucleoLIVE (nuclear dye), mortaLIVE (live-dead dye) and chromaLIVE (popular technology for drug profiling). This platform/technology is engineered for improved cell viability, cytotoxicity screening and phenotypic profiling.

The companies together will optimise other existing as well as new distribution solutions at the commercial level. The approach benefiting researchers will lead to new advancements and acceleration in drug development. The researchers will now have access to the smart platforms through this partnership. Saguaro’s portfolio will also get a broader research audience to perform excellence globally. The more alliances, more are the chances to incorporate change and positive impact into the healthcare market.

Saguaro’s dye distribution with other platforms/technology involvement is unlocking new opportunities for the company to embark on in future at a larger stage. The technology and innovation are never outdated for many individuals and companies, following which the companies' strong intervention for offering innovation and expansion will be eye-catching in future.

Leaders’ statements

The CEO and Co-founder of Saguaro, Louis Turcotte, said, “This distribution deal represents a prominent milestone for Saguaro. The bio-techne’s name of recognition for its quality and worldwide expansion makes them a perfect partner to introduce our non-toxic dyes to a massive research community (researchers), those searching for reliable and best data.”

The CCO and Co-founder of Saguaro, Felix Lavoie-Perusse, said, “Our agreement with Bio-Techne is a strong green signal and validation of our technology. This collaboration promises easy access to our reagents to biotechs, large pharmaceutical companies and academic labs, no matter what distance they are.”

The president of protein sciences at Bio-Techne, Will Geist, said, “We are thrilled to accelerate our huge, vast global distribution network to extend access to Saguaro Biosciences’s non-toxic, creative dyes. This collaboration reflects bio-techne’s dedication to serve researchers with the comprehensive technology and fulfil the critical requirements in 3D culture techniques and cell and gene therapy.”

Author

Mansi Kadam

Mansi Kadam

Mansi Kadam is a market research writer with over 3 years of experience analyzing trends in the healthcare industry. At Towards Healthcare, she covers innovations in medical sector, sustainability initiatives, and the evolving regulatory landscape.